Ventyx Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 6.72 M | $14.64 M | 15.20% | 9.50% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.91 M | $10.71 M | 100.00% | 6.95% |
CITADEL ADVISORS LLC | 11/14/2024 | 4.46 M | $9.71 M | -22.63% | 6.30% |
VANGUARD GROUP INC | 11/13/2024 | 3.47 M | $7.56 M | 15.81% | 4.91% |
FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 3.17 M | $6.91 M | 0.00% | 4.49% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 3.10 M | $6.76 M | 0.00% | 4.39% |
OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 2.39 M | $5.21 M | 0.00% | 3.38% |
REDMILE GROUP, LLC | 11/14/2024 | 2.11 M | $4.59 M | -2.63% | 2.98% |
SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.97 M | $4.30 M | 153.16% | 2.79% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.94 M | $4.22 M | 32.62% | 2.74% |
VESTAL POINT CAPITAL, LP | 11/14/2024 | 1.73 M | $3.76 M | 31.18% | 2.44% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.39 M | $3.03 M | 5.89% | 1.97% |
UBS GROUP AG | 11/14/2024 | 1.20 M | $2.61 M | 5,438.33% | 1.69% |
STATE STREET CORP | 11/14/2024 | 1.19 M | $2.59 M | 0.83% | 1.68% |
SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 1.01 M | $2.21 M | 0.00% | 1.43% |
JPMORGAN CHASE & CO | 11/08/2024 | 1.01 M | $2.20 M | 2.05% | 1.43% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 896,996 | $1.96 M | 117.12% | 1.27% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 568,479 | $1.24 M | 19.50% | 0.80% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 485,101 | $1.06 M | 3.83% | 0.69% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 465,400 | $1.01 M | 118.50% | 0.66% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 462,170 | $1.01 M | 10.15% | 0.65% |
WEXFORD CAPITAL LP | 11/14/2024 | 449,046 | $978,920 | 0.00% | 0.64% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 432,700 | $943,286 | -62.50% | 0.61% |
MACQUARIE GROUP LTD | 11/14/2024 | 430,000 | $937,000 | 0.00% | 0.61% |
QIMING U.S. VENTURES MANAGEMENT, LLC | 11/07/2024 | 412,225 | $898,651 | 0.00% | 0.58% |
WALLEYE CAPITAL LLC | 11/14/2024 | 390,102 | $850,422 | -23.63% | 0.55% |
MORGAN STANLEY | 11/14/2024 | 332,677 | $725,237 | -47.26% | 0.47% |
TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 316,195 | $689,305 | 0.00% | 0.45% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 313,700 | $683,866 | 100.00% | 0.44% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 272,869 | $594,854 | -31.66% | 0.39% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 264,870 | $577,417 | 11.87% | 0.37% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 217,658 | $473,000 | -17.42% | 0.31% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 200,000 | $436,000 | 100.00% | 0.28% |
UBS OCONNOR LLC | 11/14/2024 | 200,000 | $436,000 | 100.00% | 0.28% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 192,647 | $419,970 | -56.48% | 0.27% |
MARSHALL WACE, LLP | 11/14/2024 | 178,514 | $389,162 | 100.00% | 0.25% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 176,302 | $384,339 | -23.54% | 0.25% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 168,420 | $367,156 | 25.65% | 0.24% |
INVESCO LTD. | 11/12/2024 | 146,654 | $319,706 | -0.28% | 0.21% |
FMR LLC | 11/13/2024 | 130,886 | $285,331 | 3.03% | 0.19% |
XTX TOPCO LTD | 11/14/2024 | 112,713 | $245,714 | 100.00% | 0.16% |
AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 108,761 | $237,099 | 92.32% | 0.15% |
D. E. SHAW & CO., INC. | 11/14/2024 | 106,668 | $232,536 | 19.34% | 0.15% |
HIGHTOWER ADVISORS, LLC | 11/14/2024 | 103,955 | $227,000 | 4.52% | 0.15% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 101,330 | $220,899 | 0.00% | 0.14% |
LMR PARTNERS LLP | 11/07/2024 | 100,000 | $218,000 | 100.00% | 0.14% |
ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 97,955 | $213,542 | 656.12% | 0.14% |
RHUMBLINE ADVISERS | 11/12/2024 | 92,012 | $200,575 | 1.86% | 0.13% |
BARCLAYS PLC | 11/19/2024 | 80,295 | $175,000 | 273.14% | 0.11% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 76,007 | $166,000 | 100.00% | 0.11% |
Ventyx Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 140 institutional investors and hedge funds held shares of Ventyx Biosciences, Inc.. The most heavily invested institutionals were:
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 6.72 M
BlackRock Funding, Inc. /DE: 4.91 M
CITADEL ADVISORS LLC: 4.46 M
VANGUARD GROUP INC: 3.47 M
FARALLON CAPITAL MANAGEMENT LLC: 3.17 M
TANG CAPITAL MANAGEMENT LLC: 3.1 M
74.27% of Ventyx Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 57.72 M shares in the last 24 months. This purchase volume represents approximately $131.02 M in transactions.